DALLAS, July 28, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. (OTCBB:CBAI). The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.
Our trade alerts and ideas are provided free to investors. Simply use your email address to subscribe with http://www.microstockprofit.com to get the inside track on our next red-hot alert.
The full report is available at: http://www.microstockprofit.com/lp/CBAI
CBAI is trading within its Bollinger Bands. This is a normal condition and suggests that the stock is neither overbought nor oversold relative to the recent price action.
Cord Blood America Inc. (CBAI) is engaged in the business of collecting, testing, processing and preserving umbilical cord blood. The Company is primarily a holding company whose subsidiaries include Cord Partners Inc. (Cord), CorCell Co. Inc., CorCell Ltd., CBA Professional Services Inc. D/B/A BodyCells Inc. (BodyCells), CBA Properties Inc. (Properties), Career Channel Inc, D/B/A Rainmakers International (Rain), and Family Marketing Inc. (Family). In addition, the Company provides private cord blood stem cell preservation services to families in the United States. It also engages in collecting, processing, and preserving peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem cells for potential future use in stem cell therapy. Additionally, the Company engages in procuring and setting up call centers; editing, dubbing, and distribution of radio and television commercials; and procuring and placing print advertising, as well as provides advertising and marketing consulting services relating to the customer's marketing campaign.
Message Board Search for CBAI: http://www.boardcentral.com/boards/CBAI
In the report, the analyst notes:
"The Company announced that revenue decreased to $839,343 in the quarter ended March 31, 2010, compared to $941,938 in the same period in 2009. This reflects continued de-emphasis of Rainmakers International, Cord Blood America's advertising company, with total focus on becoming a "pure," worldwide, stem cell company.
"CBAI recently announced that it has completed all preliminary due diligence for the acquisition of a controlling interest in BioCells Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010."
To read the entire report visit: http://www.microstockprofit.com/lp/CBAI
See what investors are saying about CBAI at penny stock forum
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.